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1. Introduction 
Gas chromatography-mass pectrometry (CC-MS) 
has proved in recent years to be a valuable alternative 
and extension to the sequential degradation method 
of Edman for the determination of the amino acid 
sequence of polypeptides; for recent reviews see [ 1,2]. 
A particular polypeptide is first degraded, either by 
limited acid or by enzymatic hydrolysis, to a complex 
mixture of oligopeptides which is then suitably con- 
verted to a corresponding mixture of volatile 
derivatives. Analysis is performed with the aid of a 
CC-MS-Computer system. From the identified oligo- 
peptides the sequence of the original polypeptide is 
finally deduced. 
Such approach has been successfully applied to the 
sequence determination of polypeptides between 
20 and 39 amino acid residues long [2-61. The 
peptide derivatives used are obtained by LiAlD4- 
reduction and 0trimethylsilylation ofN-perfluoroacyl 
oligopeptide methyl esters [7] and allowed the 
identification of all amino acid residues including the 
very polar ones (arginine, histidine, tryptophan). We 
found, however, that oligopeptides containing 
asparagine and glutamine residues are derivatised with 
rather low yields and also do not chromatograph as 
well as other derivatives. Even more important, the 
asparagine and glutamine residues are completely 
hydrolysed during acid hydrolysis to aspartic and 
glutamic acid residues. Thus, the positions of the 
asparagine and glutamine residues in the polypeptides 
analysed so far by CC-MS had to be determined by 
conventional methods [4-61. Since the assignment of 
these residues is also often difficult by the Edman 
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degradation methods, an unambiguous method for 
their differentiation by GC-MS is of great potential 
significance. 
We wish to report here a new application of the 
diborane-reduction method of.Atassi and Rosenthal 
[8] for the selective modification of carboxyl groups. 
Diborane was recently also used by Airoldi and 
Doonan during the sequence analysis by the dansyl- 
Edman procedure [9]. In the approach described in 
this paper the diborane-reduced polypeptide is 
degraded by limited hydrolysis and the resulting 
oligopeptides are further reduced by LiAlD4 to 
obtain derivatives of maximum volatility. The 
differentiation between asparagine and glutamine 
and their acid analogs can unambiguously be made 
via measurement of the deuterium contents of the 
molecules by GC-MS. The carboxyl terminal amino 
acid can also be determined in the same experiment. 
2. Materials and methods 
Glucagon and the eledoisin-related peptide were 
obtained from Sigma Chem. Co.; the 1 M diborane 
solution in tetrahydrofuran was purchased from 
Aldrich. Reduction of peptides (0.4-0.8 pmol) with 
diborane was carried out at 0°C for 2 h essentially 
as described [8]. The reaction mixture was evaporat- 
ed in vacua and treated 3 times which methanol 
acidified by trifluoroacetic acid. 
The remaining dry residue was transferred with 
0.5 ml 6 N HCl (made from ‘Ultrex’ Grade, Baker 
Chem. Co.) to a hydrolysis tube, which was then 
evacuated and heated at 110°C for 30 min (eledoisin- 
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related peptide) or 35-45 min (glucagon); the 
optimum hydrolysis time was determined before the 
hydrolysis by gas chromatography with electron 
capture detection as described [lo] . The hydrolysis 
mixture was evaporated in vacua and derivatised by 
methyl esterification, trifluoroacetylation, LiA1D4- 
reduction and O-trimethylsilylation [7]. 
Aliquots of 2- 10% of the final mixture of the 
volatile derivatives were injected ‘on column’ into a 
Perkin-Elmer F-22 gas chromatograph; a 1 m glass 
column (l/4 inch o.d.) filled with 2% Dexsil300 CC 
on Chromosorb W-AW DMCS was used and the 
temperature was raised from 60°C to 340°C at a rate 
of 12.5”C/min. The column was coupled via a 
l/4 inch Swagelock union and a membrane separator 
to a MS-30 mass spectrometer (AEI, Manchester, 
England). A DS-50 data system (AEI) was used for 
the continuous acquisition of low resolution mass 
spectra (every 7 s). Selected ion records (mass 
chromatograms), i.e. plots of the intensity of ions 
vs. time, were then generated from the mass spectral 
data [ 121 to measure the deuterium content of the 
peptide derivatives. 
3. General approach 
The novel method described here is outlined 
in Scheme 1 (asparagine, aspartic acid and the 
C-terminal carboxyl group in (I) represent he potential 
reaction sites for diborane). The polypeptide (I) is 
selectively reduced by diborane - all carboxyl groups 
present are reduced to - CHa -OH groups; the primary 
amide groups of asparagine and glutamine are not 
affected. The resulting peptide (II) is then partially 
hydrolysed and the oligopeptides obtained are methyl 
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esterified and trifluoroacetylated. In the resulting 
mixture (III-V) the carboxyl groups of the aspartic 
and glutamic acid residues as well as the carboxyl 
terminal amino acid have been reduced (III,V), 
while the carboxamide groups of the side chains of 
asparagine and glutamine residues are present as 
methoxycarbonyl groups (IV). The volatility of the 
peptide derivatives is further increased by an 
exhaustive LL41D4-reduction, by which the remain- 
ing -COOCHa groups as well as all peptide bonds 
CONH- are reduced to -CD2 -OH and -CD2-NH- 
groups. Thus, in the final U-trimethylsilylated 
mixture the aspartic and glutamic acid residues as 
well as the carboxyl terminal residue are represented 
by side chains containing -CH,-OTMS groups 
(VI, VIII), while the asparagine and glutamine 
residues are represented by side chains containing 
-CD*-OTMS groups (VII). 
4. Results and discussion 
The results obtained are exemplified by the CC-MS 
data shown in fig. 1 for glucagon. This polypeptide 
contains three glutamine, three aspartic acid and one 
asparagine residues - all of which could be unambigu- 
ously identified by their mass spectra; the peptides 
containing these residues were assigned to the corres- 
ponding gas chromatographic peaks in fig. la (for 
the sake of clarity, all other peptides identified were 
omitted from fig.la, but are shown elsewhere [ 131; 
however, in that earlier experiment [ 131 no distinction 
of asparagine and glutamine from their corresponding 
acid analogs could be made). As an example, the 
selected ion records of m/e 266 and 268 are shown in 
fig. 1 b. These ions indicate dipeptides containing 
carboxyl terminal aspartic acid (266) and asparagine 
(268) residues and have the following structures: 
0 CII,-CH,OTMS 
CD*=NH-CH-CD2-OTMS 
m/e 266 
&-I,-CD,-OTMS 
CD2=NH-CH-CD*-OTMS 
m/e 268 
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Even though the two peptide derivatives Gln-Asp” 
and Met-Asnz8 were not completely separated by gas 
chromatography, their presence is clearly indicated by 
the selected ion records. The complete structure of 
the peptides present is elucidated by inspection of the 
mass spectra of the corresponding scan numbers (e.g. 
scan 129 for Gln-Asp and scan 13 1 for Met-Asn) 
and by selected ion records of other sequence ions: 
e.g., ions m/e 349 and 351 are plotted in fig.lc, 
indicating peptides with the terminal sequence Met-Asp-- 
and Met-Asn-, respectively. Indeed, one maximurn 
1600 2200 mm ml0 XC4 mm RETENTION 
INDEX 
50 100 150 200 SCAN 
, Met - Asn - Thr 
Fig.1. W-MS analysis of a mixture of oligopeptide derivatives 
obtained by selective reduction of glucagon by diborane, 
partial acid hydrolysis, methyl esterification, trifluoroacetyla- 
tion, LiAlD, reduction and O-trimethylsilylation. A sample 
of 10% of the derivatised mixture was injected into the 
@Z-MS-computer system (see Materials and methods for 
experimental details). (a) Reconstructed gas chromatogram 
(total ion plot). (b,c) Selected ion records (mass chromatograms). 
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in the plot of ion 351 (but not 349) was found at scan 
13 1 (for Met-Asn) and another one at scan 158, 
which, from additional data, was shown to be Met- 
Asn-Thr. Similarly, all other peptides shown in fig. 1 a 
were identified by computer plots of the selected ion 
records of the sequence ions. 
Thus, Gln3 of glucagon is represented by Ser-Gln 
and Gln-Gly; Asp’ by Asp-Tyr; Asp” by Leu-Asp 
and Asp-Ser; Gin*’ and Asp*’ by Ala-Gln, Ala-Gln- 
Asp, Gln-Asp and Asp-Phe; Glnm by Phe-Val-Gln, 
Val-Gln and Gln-Trp; Asn28 by Leu-Met-Asn and 
Met-Asn-Thr. 
Since the carboxyl-terminal amino acid is also 
modified by diborane, that residue can be identified 
by the mass spectral data as well. As one example, the 
threonine residue of Met-Asn-Thr eluting at scan 
158 (see above) must be derived from the carboxyl 
end of the polypeptide since the carboxyl group 
had been reduced by diborane, thus giving rise to a 
m/e 264 ion (not shown) and not to a m/e 266 ion: 
CH3 
.clI+oTMs 
CD2=NH-CH-CH2-OTMS 
m/e 264 
CH3 
0 CIH-OTMS 
CD2=NH-CH-CD*-OTMS 
m/e 266 
Ion m/e 266 would have been produced if that 
threonine residue had been derived from any other 
than the carboxyl terminal position. Also, if internal 
peptide bonds were partially reduced by diborane 
(see below), the affected bonds could neither be 
cleaved by acid nor by enzymes and thus would 
never appear at a carboxyl terminus of a fragment. 
In another experiment, the eledoisin-related 
peptide was treated with diborane prior to hydrolysis 
and derivatisation. In this case, the terminal residue 
was not affected by diborane: the carboxyl terminal 
group must therefore have been blocked in the 
original oligopeptide. 
The carboxyl groups were usually reduced by 
diborane between 40 and 80%, which leads to 
characteristic doublets in the mass spectra and 
selected ion records (fig. 1 b). Diborane reduction of 
the side chains of glutamine and asparagine was 
negligible (fig.1~). Diborane reduction of the peptide 
bonds of the polypeptides investigated was usually 
below 1% with the exception of the carboxyl 
terminal peptide bond, which was reduced to a con- 
siderable extent: e.g., the carboxyl terminal peptide 
bond @u-Met-NH*) in the eledoisin-related 
peptide as judged from the relative areas of the 
selected ion records of ion m/e 287 and 289 (sequence 
ion of Leu-Met- ) was calculated to be 36-38%. 
Partial reduction of peptide bonds by diborane does 
not significantly decrease the yields obtained (which 
was the case when the diborane-reduction was applied 
during the dansyl-Edman procedure [9]), since all 
peptide bonds are reduced subsequently by LiAlD,; 
by interpreting the mass spectral data of the resulting 
derivatives, one can easily distinguish between the 
diborane-reduction of the carboxyl groups of the side 
chains and of the peptide bonds. 
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